BABA vs MLR

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

MLR exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.08, indicating a fortress balance sheet. However, this financial stability is contrasted by a severe collapse in growth, with YoY earnings plummeting 67.10% and revenue declining 22.50%. While the stock trades near its Graham Number ($40.59), it is significantly above its growth-based intrinsic value ($13.86), suggesting the market is pricing in a recovery that is not yet evident in the data. The outlook remains neutral as the company's operational efficiency is currently offset by its exceptional solvency.